SOFIE
Website to be confirmed.
About SOFIE
A CDMO / CMO player with a presence on the SNMMI floor; commercial activity worth a closer look.
Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.
What we're seeing
- BioPharma Reporter · 2026-02-15Sofie publishes dosimetry data at SNMMI 2026The announcement comes amid tightening Mo-99 and Lu-177 supply.
- FierceBiotech · 2026-09-08Sofie closes Series C round to scale radiopharma manufacturingDetails remain limited but analysts read the move as a positioning play ahead of pivotal data.
- Endpoints News · 2026-08-01Sofie partners with academic center on Actinium-225 programDetails remain limited but analysts read the move as a positioning play ahead of pivotal data.
- Reuters Health · 2026-11-22Sofie files IND for next-generation PSMA-targeted agentIndustry observers expect more activity of this kind in the run-up to SNMMI 2026.
Mocked while we wire the Exa integration. Headlines are illustrative.
What we expect to see at the booth
Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.
A short Bracken POV will go here, drawing on our experience across this part of the radiopharma value chain. Specific commentary to be filled in by the team.
Editorial shown for exhibitors in Bracken's wheelhouse: radiopharma developers, isotope supply, CDMO/CMO, cyclotron, and imaging equipment.
Companies you may also want to visit.
AtomVie Global Radiopharma Inc.
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on AtomVie Global Radiopharma Inc..
View profile →CDL Nuclear Technologies
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on CDL Nuclear Technologies.
View profile →Jubilant Radiopharma
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on Jubilant Radiopharma.
View profile →